{"id":"bamethan","rwe":[],"tags":[{"label":"bamethan","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"C04AA31","category":"atc"},{"label":"Active","category":"status"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Vasodilator Agents","category":"pharmacology"}],"phase":"phase_2","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"bametan","offLabel":[],"synonyms":["bamethan sulfate","bamethan","bametan","bamethane","butedrine","butylnorsynephrine","butylsympatol","DL-Bamethane","N-Butylnorsynephrine","N-Butyloctopamine"],"timeline":[],"brandName":"Bametan","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"bamethan","explanation":"Imagine your body's cells have locks on them, and the key to unlocking the right response is a specific molecule. Bametan is designed to fit into this lock, allowing the cell to respond in a way that treats the underlying condition. This is a simplified explanation of how bamethan drugs like Bametan are thought to work.","oneSentence":"Bametan is thought to work by interacting with a specific molecular target to produce its therapeutic effects.","technicalDetail":"Bametan is a small molecule that binds to a specific protein target, modulating its activity and producing a therapeutic response."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/286","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BAMETHAN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:56:53.774083","biosimilars":[],"competitors":[{"drugName":"isoxsuprine","drugSlug":"isoxsuprine","fdaApproval":"","relationship":"same-class"}],"genericName":"bamethan","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"isoxsuprine","brandName":"isoxsuprine","genericName":"isoxsuprine","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"004288","UNII":"Y08ZFJ9TFK","CHEBI":"CHEBI:31251","INN_ID":"995","RXNORM":"102345","UMLSCUI":"C0004718","ChEMBL_ID":"CHEMBL1987462","KEGG_DRUG":"D01673","DRUGBANK_ID":"DB13206","PUBCHEM_CID":"2292","SNOMEDCT_US":"391813004","SECONDARY_CAS_RN":"5716-20-1","MESH_SUPPLEMENTAL_RECORD_UI":"C084810"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":61,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"C04AA31","allCodes":["C04AA31"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bametan (BAMETHAN) is a small molecule drug in the bamethan class, but specific details about its target, indications, and pharmacokinetics are unknown. Its commercial status, including patent status and generic availability, is also unclear. As a result, there is limited information available about its use in clinical practice. Bametan's mechanism of action and safety profile are not well-documented. Further research is needed to fully understand its potential benefits and risks.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}